Cargando…

How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir

Detalles Bibliográficos
Autores principales:	Das, Atze T., Berkhout, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893875/ https://www.ncbi.nlm.nih.gov/pubmed/29636435 http://dx.doi.org/10.1128/mBio.00006-18

Ejemplares similares

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
por: Malet, Isabelle, et al.
Publicado: (2018)

Variability in HIV-1 Integrase Gene and 3′-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy
por: Acharya, Arpan, et al.
Publicado: (2020)

7‐Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir
por: Ziegler, Robert E., et al.
Publicado: (2018)

Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor
por: Nilavar, Namrata M., et al.
Publicado: (2020)

In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
por: Smith, Robert A, et al.
Publicado: (2015)

HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action?
por: Berkhout, Ben, et al.
Publicado: (2012)

Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
por: Dow, Dorothy E., et al.
Publicado: (2014)

Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase
por: Figiel, Małgorzata, et al.
Publicado: (2018)

The Allosteric HIV-1 Integrase Inhibitor BI-D Affects Virion Maturation but Does Not Influence Packaging of a Functional RNA Genome
por: van Bel, Nikki, et al.
Publicado: (2014)

Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir
por: Song, Ivy, et al.
Publicado: (2014)

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018)

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
por: Wang, Gang, et al.
Publicado: (2016)

Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens
por: Gil, Horacio, et al.
Publicado: (2022)

On the primer binding site mutation that appears and disappears during HIV and SIV replication
por: Berkhout, Ben, et al.
Publicado: (2015)

Opening of the TAR hairpin in the HIV-1 genome causes aberrant RNA dimerization and packaging
por: Das, Atze T, et al.
Publicado: (2012)

SiRNA-Induced Mutation in HIV-1 Polypurine Tract Region and Its Influence on Viral Fitness
por: Rausch, Jason W., et al.
Publicado: (2015)

Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
por: Voges, Maike, et al.
Publicado: (2016)

CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
por: Binda, Caroline S., et al.
Publicado: (2020)

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
por: Tao, Kaiming, et al.
Publicado: (2023)

Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics
por: DeAnda, Felix, et al.
Publicado: (2013)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome
por: Westerhout, Ellen M., et al.
Publicado: (2005)

Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands
por: Turner, Kevin B., et al.
Publicado: (2008)

INSTIs and NNRTIs Potently Inhibit HIV-1 Polypurine Tract Mutants in a Single Round Infection Assay
por: Smith, Steven J., et al.
Publicado: (2021)

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
por: Darcis, Gilles, et al.
Publicado: (2018)

Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study
por: Underwood, Mark, et al.
Publicado: (2022)

Deep sequencing of small TAR-derived RNAs in HIV-1 producing cells
por: Harwig, Alex, et al.
Publicado: (2011)

Characterization of microRNAs derived from the HIV-1 TAR RNA hairpin
por: Harwig, Alex, et al.
Publicado: (2013)

The RNA structure of the major splice donor site controls HIV-1 splicing
por: Mueller, Nancy, et al.
Publicado: (2013)

Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
por: Liu, Ye, et al.
Publicado: (2021)

Probing Resistance Mutations in Retroviral Integrases by Direct Measurement of Dolutegravir Fluorescence
por: Thierry, Eloïse, et al.
Publicado: (2017)

On the generation of the MSD-Ѱ class of defective HIV proviruses
por: Das, Atze T., et al.
Publicado: (2019)

Update on Adverse Effects of HIV Integrase Inhibitors
por: Kolakowska, Agnieszka, et al.
Publicado: (2019)

The viral Tat protein has no essential function in HIV-1 replication other than to activate transcription
por: Das, Atze T, et al.
Publicado: (2009)

A Phylogenetic Survey on the Structure of the HIV-1 Leader RNA Domain That Encodes the Splice Donor Signal
por: Mueller, Nancy, et al.
Publicado: (2016)

Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA
por: Boutimah-Hamoudi, Fatima, et al.
Publicado: (2007)

Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis
por: Betancor, Gilberto, et al.
Publicado: (2015)

In vivo SELEX of single-stranded domains in the HIV-1 leader RNA
por: van Bel, Nikki, et al.
Publicado: (2013)

HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants
por: Smith, Steven J., et al.
Publicado: (2021)

HIV-1 splicing is modulated by RNA structure
por: Müller, Nancy, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eoktogcsqojoc9pvb71p9l4em8